Figure 4.

Uncertainty analysis of percentage reduction of malaria transmission from using dihydroartemisinin-piperaquine (DP) compared with artemether-lumefantrine (AL). Probabilistic uncertainty analysis was conducted for a different level of treatment coverage: 40%, 60%, and 80% of clinically infected individuals seek treatment. Individuals are all treated with AL or DP. The difference in effectiveness between DP and AL was measured in terms of (A) percentage reduction in malaria prevalence and (B) prevented episodes of clinical malaria per person annually.